Juan Jose Alegre
Overview
Explore the profile of Juan Jose Alegre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Narvaez J, Aguilar-Coll M, Vicens-Zygmunt V, Alegre J, Bermudo G, Molina-Molina M
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685534
: Interstitial lung disease (ILD) is one of the most severe complications of rheumatoid arthritis (RA). Real-world data on antifibrotic treatment are needed. Our objective was to evaluate the real-world...
2.
Narvaez J, Canadillas E, Castellvi I, Alegre J, Vicens-Zygmunt V, Bermudo G, et al.
Arthritis Res Ther
. 2024 Jul;
26(1):128.
PMID: 38982531
No abstract available.
3.
Narvaez J, Canadillas E, Castellvi I, Alegre J, Vicens-Zygmunt V, Bermudo G, et al.
Arthritis Res Ther
. 2024 Jun;
26(1):122.
PMID: 38890654
Objective: To assess the real-world, long-term effectiveness of rituximab (RTX) as a rescue therapy in patients with antisynthetase syndrome and progressive interstitial lung disease (ASS-ILD). Methods: Multicentre observational retrospective longitudinal...
4.
Narvaez J, Robles-Perez A, Molina-Molina M, Vicens-Zygmunt V, Luburich P, Yanez M, et al.
Semin Arthritis Rheum
. 2020 Sep;
50(5):902-910.
PMID: 32906025
Objective: To assess the real-world, long-term effectiveness of rituximab (RTX) as a rescue therapy in patients with progressive rheumatoid arthritis-related interstitial lung disease (RA-ILD) in whom more conventional therapy has...
5.
Castellvi I, Eguiluz S, Escudero-Contreras A, Rios J, Calvo-Alen J, Callejas-Rubio J, et al.
Rheumatol Int
. 2019 Sep;
39(11):1875-1882.
PMID: 31522232
The objective of this study was to evaluate the impact of digital ulcers (DUs) in daily life of systemic sclerosis (SSc) Spanish patients. We developed a multicenter observational study to...
6.
Rua-Figueroa I, Lopez-Longo J, Galindo-Izquierdo M, Calvo-Alen J, Del Campo V, Olive-Marques A, et al.
Semin Arthritis Rheum
. 2017 Mar;
47(1):38-45.
PMID: 28259425
Objectives: To estimate the incidence of severe infection and investigate the associated factors and clinical impact in a large systemic lupus erythematosus (SLE) retrospective cohort. Methods: All patients in the...
7.
Borrell H, Narvaez J, Alegre J, Castellvi I, Mitjavila F, Aparicio M, et al.
Medicine (Baltimore)
. 2016 Aug;
95(33):e4626.
PMID: 27537601
Shrinking lung syndrome (SLS) is a rare and less known complication mainly associated with systemic lupus erythematosus (SLE). In this study, we analyze the clinical features, investigation findings, approaches to...
8.
Pego-Reigosa J, Lois-Iglesias A, Rua-Figueroa I, Galindo M, Calvo-Alen J, de Una-Alvarez J, et al.
Rheumatology (Oxford)
. 2016 Mar;
55(7):1243-50.
PMID: 27018057
Objectives: To identify patterns (clusters) of damage manifestations within a large cohort of SLE patients and evaluate the potential association of these clusters with a higher risk of mortality. Methods:...